Risk Factors and Incidence of Posttransplant Diabetes Mellitus in Mexican Kidney Recipients

Archives of Medical Research

Volumn 37, Issue 8, 2006, Pages 961-966

  Andrade Sierra, Jorge ^a,b   Contreras, Ana M ^a,b   Monteon, Francisco J ^a,b   Celis, Alfredo ^a,b   Gutierrez, Rodolfo ^b   Montañez, Jose L ^a,b   Ruelas, Sara ^a,b   Baid Agrawal, Seema ^c   Chung, Raymond T ^d   The Mexican Cooperative Group for the Study of Hepatitis in Kidney Diseases, ^e  

^a Specialties Hospital   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e Harvard Medical School ^*

Author keywords

Incidence; Kidney transplant; Posttransplant diabetes mellitus (PTDM); Risk factors

Indexed keywords

ACICLOVIR; AZATHIOPRINE; BASILIXIMAB; COTRIMOXAZOLE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; OKT 3; PREDNISONE;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIABETES MELLITUS; DIABETOGENESIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HUMAN; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; TIME SERIES ANALYSIS;

ADULT; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MEXICO; MIDDLE AGED; RISK FACTORS;

EID: 33749595623     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2006.05.004     Document Type: Article

References (32)

1. Miles A.M., Sumrani N., Horowitz R., Homel P., Maursky V., Markel M.S., et al. Diabetes mellitus after renal transplantation. As deleterious as non-transplant associated diabetes?. Transplantation 65 (1998) 380-384
2. Cosio F.G., Kudva Y., Vander Velde M., Larson T.S., Textor S.C., Griffin M.D., et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 67 (2005) 2415-2421
3. Nam J.H., Mun J.I., Kim S.I., Kang S.W., Choi K.H., Park K., et al. Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of post-renal transplantation diabetes mellitus. Transplantation 71 (2001) 1417-1423
4. Roth D., Milgrom M., Esquenazi V., Fuller L., Burke G., Miller J., et al. Post-transplant hyperglycemia: increased incidence in cyclosporine-treated renal allograft recipients. Transplantation 47 (1989) 278-281
5. Pirsch J.D., Miller J., Deierhoi M.H., Vicenti F., and Filo R.S. A comparison of tacrolimus (FK 506) and cyclosporine for imunosuppression after cadaveric renal trasplantation: FK 506 Kidney Transplant Study Group. Transplantation 63 (1997) 977-983
6. Yale J.F., Chamelian M., Courchesne S., and Vigeant C. Peripheral insulin resistance and decreased insulin secretion after cyclosporine A treatment. Transplant Proc 20 (1998) 985-988
7. Cosio F.G., Pesavento T.E., Osei K., Henry M.L., and Ferguson R.M. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 59 (2001) 732-737
8. Vesco L., Busson M., Bedrossian J., Bitker M.O., Hiesse C., and Lang P. Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors. Transplantation 61 (1996) 1475-1478
9. Kasiske B.L., Snyder J.J., Gilbertson D., and Matas A.J. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3 (2003) 178-185
10. Sumrani N.B., Delaney V., Ding Z.K., Davis R., Daskalakis P., Friedman E.A., et al. Diabetes mellitus after renal transplantation in the cyclosporine era: an analysis of risk factors. Transplantation 51 (1991) 343-347
11. Baid S., Tolkoff-Rubin N., Farrell M.L., Delmonico F.L., Williams W.W., Hayden D., et al. Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection. Transplant Proc 34 (2002) 1771-1773
12. Davidson J., Wilkinson A., Dantal J., Dotta F., Haller H., Hernandez D., et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation 75 (2003) S3-S24
13. Arner P., Gunnarsson R., Blomdahl S., and Groth C.G. Some characteristics of steroid diabetes: a study in renal transplant recipients receiving high dose corticosteroid therapy. Diabetes Care 6 (1983) 23-25
14. Van Hoof Johannes P., Christiaans Maarten H.L., and Van Duijnhoven Elly M. Tacrolimus and post-transplant diabetes mellitus in renal transplantation. Transplantation 79 (2005) 1465-1469
15. Jindal R.M., Sidner R.A., and Milgrom M.L. Post-transplant diabetes mellitus. The role of immunosuppression. Drug Safety 16 (1997) 242-257
16. NMH-DIA. Diabetes estimates 1995-2025 (2001), World Health Organization, Geneva
17. Barquera S., Tovar-Guzmán V., Campos-Nonato I., Gonzalez-Villalpando C., and Rivera-Dommarco J. Geography of diabetes mellitus mortality in Mexico: an epidemiologic transition analysis. Arch Med Res 34 (2003) 407-414
18. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Craviota P, et al. Encuesta Nacional de Salud 2000. Tomo 2. La Salud de los adultos. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública (ISBN 968-6502-72-6);2003:94-103.
19. Monteon F.J., Gómez B., Valdespino C., Chavez S., Sandoval M., Flores A., et al. The Kidney Transplant Experience at hospital de Especialidades, Centro Médico Nacional de Occidente, IMSS, Guadalajara México. In: Cecka J.M., and Terasaki P. (Eds). Clinical Transplants (2003), UCLA Immunogenetics Center, Los Angeles 165-174
20. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26 suppl 1 (2003) S5-S20
21. Racusen L.C., Colvin R.B., Solez K., Mihatsch M.J., Halloran P.F., Campbell P.M., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 (1999) 713-723
22. Yamamoto H., Akazawa S., Yamaguchi Y., Yokota A., Yamasaki H., Nakanishi T., et al. Effects of cyclosporin A and low dosages of steroid on post-transplantation diabetes in kidney transplant recipients. Diabetes Care 14 (1991) 867-870
23. Ford C.S. Leukocyte count, erythrocyte sedimentation rate and diabetes incidence in a national sample of US adults. Am J Epidemiol 155 (2002) 57-64
24. Festa A., Hanley A.J., Tracy R.P., D'Agostino Jr. R., and Haffner S.M. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 108 (2003) 1822-1830
25. Hricik D.E., Bartucci M.R., Moir E.J., Mayes J.T., and Schulak J.A. Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation 51 (1991) 374-377
26. Hjelmesaeth J., Hartmann A., Kofstad J., Stenstrom J., Leivestad T., Egeland T., et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 64 (1997) 979-983
27. Weir M.R., and Fink J.C. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 34 (1999) 1-13
28. Sato T., Inagaki A., Uchida K., Ueki T., Goto N., Matsuoka S., et al. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Transplantation 76 (2003) 1320-1326
29. Gentil M.A., Rocha J.L., Pereira P., Algarra G.R., and Lopez R. High incidence of diabetes mellitus after kidney transplant in patients with hepatitis C. Nephron 82 (1999) 85
30. Bloom R.D., Rao V., Weng F., Grossman R.A., Cohen D., and Mange K.C. Association of hepatitis C with postransplant diabetes in renal patients on tacrolimus. J Am Soc Nephrol 13 (2002) 1374-1380
31. Markell M. New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management. Am J Kidney Dis 43 (2004) 953-965
32. Van Hooff J.P., Christiaans M.H., and van Duijnhoven E.M. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant 19 suppl 6 (2004) Vi8-Vi12